Editorial: how widespread and serious is non-alcoholic fatty liver disease in the real world?
- PMID: 32424922
- DOI: 10.1111/apt.15714
Editorial: how widespread and serious is non-alcoholic fatty liver disease in the real world?
Comment in
-
Editorial: how widespread and serious is non-alcoholic fatty liver disease in the real world? Authors' reply.Aliment Pharmacol Ther. 2020 Jun;51(11):1200-1201. doi: 10.1111/apt.15724. Aliment Pharmacol Ther. 2020. PMID: 32424927 No abstract available.
Comment on
-
Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data.Aliment Pharmacol Ther. 2020 Jun;51(11):1149-1159. doi: 10.1111/apt.15679. Epub 2020 May 5. Aliment Pharmacol Ther. 2020. PMID: 32372515
References
REFERENCES
-
- Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of non-alcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence and outcomes. Hepatology. 2016;64:73-84.
-
- Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274-285.
-
- Singh S, Allen AM, Wang Z, et al. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015;13:643-654.e9; quiz e39-40.
-
- Loomba R, Wong R, Fraysse J, et al. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data. Aliment Pharmacol Ther. 2020. https://doi.org/10.1111/apt.15679
-
- https://www.liverscreen.eu/. Accessed 8/3/2020.